WC
The startup develops immunotherapy cancer treatments utilizing CRISPR and mRNA technologies to create a universal cancer vaccine and conventional immunotherapy options. This approach enables researchers and institutions to enhance their cancer vaccine portfolios, addressing the need for more effective cancer therapies.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops immunotherapy cancer treatments utilizing CRISPR and mRNA technologies to create a universal cancer vaccine and conventional immunotherapy options. This approach enables researchers and institutions to enhance their cancer vaccine portfolios, addressing the need for more effective cancer therapies.